Peripartum Cardiomyopathy: Epidemioclinical, Therapeutic and Evolutionary Aspects in the Cardiology Department of the Kati University Hospital

Objectives: Peripartum cardiomyopathy (PPCM) is the occurrence of congestive heart failure in the preceding month and five (5) months following delivery in the absence of previously known cardiovascular disease or risk factors. The aim of this work was to study its epidemiological-clinical, paraclinical, therapeutic and evolutionary aspects. Methods: This was a descriptive cross-sectional study from January 2016 to December 2023 in the cardiology department of Kati University Hospital. Any woman admitted for heart failure between the eighth month of pregnancy and the first five months postpartum without an etiology found and a dilated cardi omyopathy found on echocardiography was included. Results: In our study, the prevalence of CMPP was 25.3%. The average age was 28.4±7.9 years. More than half of the patients were multiparous. Symptoms began mainly in the postpartum period (73%). The average treatment time was 61.8 ± 49.8 days. Dyspnea was present in all patients. The central signs were dominated by tachycardia (92.1%) and the peripheral signs by turgor of the jugular veins (77.8%). Global heart failure (77.8%) was its main mode of expression. Sinus tachycardia (80.0%) was the dominant electrical sign. Global hypokinesia, left ventricular dilation and systolic dysfunction were the main echocardiographic abnormalities. His treatment was for heart failure. The evolution was favorable in 96.8%. Conclusions: This is a common pathology characterized by a delay in diagnosis and a generally favorable outcome.